Agreement of the Point of Care Test (POCT) Boditech iCHROMA™ Covid-19 IgG Antibody Assay with the Abbott Architect SARSCoV- 2 IgG Antibody Assay

Abstract

Introduction: Allergic Rhinitis (AR) is a non-infectious epidemic which can be prevented and controlled effectively with good quality of life in compliant children following the conventional inhalational therapies diligently. Paediatric Rhino-conjunctivitis Quality of Life Questionnaire (PRQLQ), devised by Professor Elizabeth Juniper is a validated questionnaire consisting of 23 parameters in 5domains. It is one of the best possible ways to judge the clinical severity and improvement in the affected children. Aims and Objectives:To study the clinical profile in childhood Asthma and Allergic Rhinitis. Material and Methods:The study included 30patients in the age group of 6to12years diagnosed with Allergic Rhinitis. The Quality of Life was analysed using Paediatric Rhino-conjunctivitis Quality of Life Questionnaire (PRQLQ).Results: Cough featured in (90%) of the subjects followed by sneezing, rhinorrhoea and nose block. Allergic shiners were seen in (63%) children followed by Deviated Nasal Septum (DNS) in (46.7%) and Inferior turbinate hypertrophy (ITH) in (40%) cases. The Quality of Life parameters revealed nasal symptoms (100%), Practical problems (80%) and Activity limitations (70%). Majority of the subjects had mild affection (66.7%) in different domains of PRQLQ. Asthma was the most common comorbidity (90%) and family history of Allergic Rhinitis featured in (66.7%) cases. Conclusion:All the domains of PRQLQ have to be critically evaluated in childhood AR. The questionnaire would aid in clinical assessment, therapeutic alterations and over all well-being of the child.

Effect of the Addition of eCG on day 14 Post-Ftai on the Pregnancy Rate in Cows from The Ecuadorian Amazon

“…The sensitivity of the minimum detectable concentration of progesterone is distinguished in a working range: 0.127 to 127.2nmol/L and 0.4-40ng/mL with a confidence limit of 99%. The intra-assay coefficient of variation (CV) was low (5.2%) and high (6.2%) (Boditech, 2020).…”